Track market-moving stories before they get noisy

Collins Aerospace lab completes Clean Aviation SWITCH testing and moves on to LEIA project

, /PRNewswire/ -- Farnborough International Air Show – Collins Aerospace, an RTX (NYSE: RTX) business, has completed integrated lab testing for the European Union's Clean Aviation SWITCH project at The Grid, its advanced electric power systems lab in Rockford, Ill. The tested hybrid-electric powertrain subsystems, which successfully operated with simulated aircraft and engine systems, are now headed to Airbus's laboratories for further aircraft level integration testing, including work on aircraft design, battery interfacing and energy-management systems.

"This is the largest integrated systems test conducted at The Grid since its opening in 2023," said Kristin Smith, vice president of Electric Power Systems at Collins Aerospace.  "By combining our technology expertise with deep industry collaboration, we are demonstrating how hybrid-electric systems can significantly reduce fuel consumption for next-generation aircraft."   

SWITCH aims to improve engine efficiency for future short- and medium-range aircraft by integrating hybrid-electric systems on a Pratt & Whitney GTF™ engine, including two Collins megawatt class motor generators and controllers. Testing at The Grid was supported by Pratt & Whitney teams who performed powertrain system integration and supplied the hybrid-electric engine controller, and Airbus teams who supplied the interface controller to the aircraft energy-management system. GKN Aerospace delivered the high-voltage wiring system.

Next, The Grid will support the Airbus-led LEIA (Large scalE Integration demonstrator of hybrid electrical Architecture) project, where Collins is technical lead for energy sources. This Clean Aviation demonstrator advances components and aircraft systems for future hybrid-electric short- and medium-range aircraft, including high voltage generation and distribution.

Collins will deliver advanced aircraft electric system technologies, including four scalable electric motor/generators, next-generation electronic controllers, power distribution equipment, and cabin pressure and ventilation control systems to enhance reliability and passenger comfort. The Nördlingen, Germany site will supply solid-state power controllers and power distribution panels to replace mechanical circuit breakers and relays boosting reliability and reducing weight. LEIA testing will occur across several sites, including The Grid, with additional work at Collins' facilities in Toulouse, France; Frankfurt, Germany; Cork, Ireland; Rome, Italy; and Solihull, UK.

According to Pierre Durel, Project Officer at Clean Aviation, "SWITCH & LEIA are essential building blocks to make the hybrid-electric short- and medium-range aircraft become a reality: they show the power of collaboration within Europe and beyond." He adds that Clean Aviation is "very much looking forward to the results of the demonstration tests due to be carried out in 2027."

Both SWITCH and LEIA build on the ongoing collaboration between Collins and several partners across multiple Clean Aviation projects, including HECATE and AWATAR, which advance electrification technologies for future regional and short-and-medium range aircraft. Collins also contributes to Clean Aviation's newest ultra-efficient regional aircraft projects, including OSYRYS and PHARES. MTU Aero Engines coordinates the SWITCH project. 

About Collins Aerospace
Collins Aerospace, an RTX business, provides advanced aerospace and defense solutions across avionics, aircraft interiors, aerostructures and engine components, mission systems, and power and control systems. Our global employees are dedicated to delivering innovative technologies to enhance aircraft performance, passenger comfort, operational safety and reliability. 

About RTX
With more than 180,000 global employees, we push the limits of technology and science to redefine how we connect and protect our world. With industry-leading capabilities, we advance aviation, engineer integrated defense systems for operational success, and develop next-generation technology solutions and manufacturing to help global customers address their most critical challenges. The company, with 2025 sales of more than $88 billion, is headquartered in Arlington, Virginia. 

About the Clean Aviation Joint Undertaking  
The Clean Aviation Joint Undertaking is the European Union's leading research and innovation programme for transforming aviation towards a sustainable and climate-neutral future. It is a successful European public-private partnership between the European Commission through Horizon Europe, the EU research and innovation programme, and the European aeronautics industry. It has a budget of €4.1 billion divided into €1.7 billion in EU funding and no less than €2.4 billion in private funding. The programme's disruptive clean aviation technologies will help reduce the emission footprint of short-medium range and regional aircraft by no less than 30% compared to 2020 state-of-the-art aircraft. Clean Aviation builds on the knowledge and expertise of the Clean Sky programmes (2008-2024). 

For questions or to schedule an interview, please contact [email protected].

SOURCE RTX

Broadcom remains essential in global tech, supplying critical chips and enabling hyperscalers to build custom silicon, challenging Nvidia's dominance. The renewed $30 billion, 6-year Apple deal secures AVGO's position in Apple's supply chain, maintaining a ~$5 billion annual revenue stream. AVGO's collaboration with OpenAI on custom AI processors highlights its role as an irreplaceable 'pick and shovel' provider in the AI infrastructure shift.

Posted by Defense World Staff on Jul 22nd, 2026

Vitro Diagnostics (OTCMKTS:VODG – Get Free Report) and Biogen (NASDAQ:BIIB – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends.

Profitability This table compares Vitro Diagnostics and Biogen’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets Vitro Diagnostics -444.35% N/A -195.51% Biogen 13.81% 12.83% 8.01% Institutional & Insider Ownership 87.9% of Biogen shares are owned by institutional investors. 27.7% of Vitro Diagnostics shares are owned by company insiders. Comparatively, 0.3% of Biogen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations This is a breakdown of current ratings and recommmendations for Vitro Diagnostics and Biogen, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vitro Diagnostics 0 0 0 0 0.00 Biogen 2 12 17 1 2.53 Biogen has a consensus target price of $220.57, indicating a potential upside of 8.57%. Given Biogen’s stronger consensus rating and higher probable upside, analysts plainly believe Biogen is more favorable than Vitro Diagnostics.

Valuation and Earnings This table compares Vitro Diagnostics and Biogen”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Vitro Diagnostics $2.06 million N/A -$10.85 million ($2.21) -0.18 Biogen $9.89 billion 3.03 $1.29 billion $9.32 21.80 Biogen has higher revenue and earnings than Vitro Diagnostics. Vitro Diagnostics is trading at a lower price-to-earnings ratio than Biogen, indicating that it is currently the more affordable of the two stocks.

Summary Biogen beats Vitro Diagnostics on 11 of the 12 factors compared between the two stocks.

About Vitro Diagnostics (Get Free Report)

Vitro Diagnostics, Inc., doing business as Vitro Biopharma, focuses on the development, manufacture, and distribution of stem cell products and related tools for use in research, drug discovery, and clinical trials in the United States. Its stem cell technology includes cell lines, supporting products, and methods for generation and differentiation of stem cells into products for the treatment of diseases, such as heart disease, arthritis, multiple sclerosis, brain injury, autism, stroke, Parkinson's, and Alzheimer's diseases. The company also offers Tools for Stem Cell and Drug Discovery that provide researchers basic tools needed to advance stem cell technology, including stem cells and their derivatives; media for growth and differentiation of stem cells; and tools for measurement of stem cell quality, potency, and response to toxic agents. In addition, it offers MSC-Gro, a cell culture media product; MSC cell line for the treatment of skeletal muscular conditions, such as tendonitis, ligament injury, osteoarthritis and accelerated bone fracture healing, etc.; and testing and therapies related to endogenous stem cell activation. Further, the company provides diagnostic testing of stem cell activation and determination of stem cell functional status; and cell-based assays for discovery of novel stem cell activation agents and drugs for the treatment of osteoporosis. Vitro Diagnostics, Inc. was founded in 1986 and is based in Golden, Colorado.

About Biogen (Get Free Report)

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; ADUHELM to treat Alzheimer’s disease; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE; and BYOOVIZ, a ranibizumab biosimilar referencing LUCENTIS. It offers RITUXAN for treating non-Hodgkin’s lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin’s lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for non-Hodgkin’s lymphoma; and other anti-CD20 therapies. In addition, the company is developing various products for the treatment of MS, Alzheimer’s disease and dementia, neuromuscular disorders, Parkinson’s disease and movement disorders, neuropsychiatry, genetic neurodevelopmental disorders, and biosimilars, which are under various stages of development. It has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis Co., Ltd.; Sangamo Therapeutics, Inc.; and Sage Therapeutics, Inc., as well as collaboration with Fujirebio to potentially identify and develop blood-based biomarkers for tau pathology in the brain. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.

Receive News & Ratings for Vitro Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitro Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEContrasting OBOOK (NASDAQ:OWLS) & Doximity (NYSE:DOCS)

NEXT HEADLINE »Conexeu Sciences (CNXU) vs. Its Peers Financial Survey

Evropské futures kontrakty mírně posilují

Vaxart (OTCMKTS:VXRT) held its 2026 Annual Meeting of Stockholders, where investors re-elected the company’s full slate of directors, ratified its auditor and rejected the company’s non-binding advisory proposal on executive compensation.

Mark Watson, Vaxart’s lead independent director and chair of the meeting, said proxies had been received for 110,631,100 of the company’s 242,044,838 outstanding shares of common stock entitled to vote as of the May 26, 2026, record date. That represented about 45.71% of eligible shares and constituted a quorum.

Stockholders Elect Directors, Reject Say-on-Pay Proposal Stockholders approved the election of James B. Breitmeyer, M.D., Ph.D.; Kevin P. Finney; Elaine J. Heron, Ph.D.; Steven Lo; W. Mark Watson, CPA; and David Wheadon, M.D., as directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified.

Investors also approved the ratification of WithumSmith+Brown, PC as Vaxart’s independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.

However, Watson said the company’s non-binding advisory vote on the compensation of named executive officers, referred to as the say-on-pay proposal, “did not pass.” Vaxart said it expects to report preliminary voting results, or final results if available, in a Form 8-K filing with the Securities and Exchange Commission within four business days of the meeting.

Management Says No Reverse Split Is Currently Planned Several stockholder questions focused on whether Vaxart would pursue a reverse stock split. Steven Lo, Vaxart’s president and chief executive officer, said the company is “not working on a reverse stock split at the present moment.”

Lo said Vaxart is focused on executing its corporate strategy, including completing its COVID-19 study and seeking potential norovirus partnerships. In response to a question about shareholder feedback, Lo said the company did not propose a reverse split at the annual meeting because it had heard from stockholders.

“Your opinion does matter,” Lo said.

Asked whether management anticipated calling a special meeting to revive a reverse split initiative, Lo said there is no current plan for a special meeting. He added that the company would prefer to execute its plan and, in a best-case scenario, see the stock price grow organically.

COVID-19 Program and BARDA-Backed Study Discussed Lo addressed questions about the 400-participant sentinel cohort data from Vaxart’s COVID-19 vaccine study. He said the company had announced top-line 12-month safety data from the cohort on July 6 and directed investors to the company’s press release for more detail.

Lo said Vaxart was “very happy” with the safety findings, including systemic effects, and said the Vaxart cohort “did much better than the mRNA” comparator on certain safety measures. He said the findings reinforced the safety of the company’s oral vaccine platform, noting that Vaxart has cumulatively dosed more than 1,000 subjects across studies.

On efficacy, Lo said the 400-participant cohort was not powered or designed to compare efficacy against mRNA vaccines. Still, he said the numbers were “certainly very close” and that Vaxart was encouraged by the results as it moves into a 5,000-subject cohort.

Lo said the sentinel 400 cohort targeted the XBB strain, matching the mRNA comparator used at that time. For the 5,000-participant cohort, he said the vaccine was updated to target the KP.2 strain, again matching the mRNA comparator. He also said the program uses Vaxart’s current second-generation constructs.

Regarding BARDA funding, Lo said Vaxart remains one of the few companies with a COVID-19 program agreement with BARDA after the agency canceled many projects in 2025. He said weekly interactions with BARDA could help position Vaxart for future opportunities, though any additional funding would depend on BARDA’s priorities and available budget.

Norovirus Partnerships Remain a Focus Lo said Vaxart has maintained ongoing conversations with various companies regarding a potential norovirus partnership. He emphasized that the company views the norovirus asset as highly valuable and would only be interested in offers that reflect what management sees as the full potential of the market.

“We only are going to be interested in offers that realize the full value of the potential of the norovirus market,” Lo said, adding that Vaxart believes it has one of the only norovirus vaccine candidates in development.

Asked about advancing the norovirus pipeline into a Phase II clinical study, Lo said the timing depends on additional funding and, at this point, would require a partnership commitment.

Cash Runway, Funding Efforts and Other Pipeline Updates Jeroen Grasman, Vaxart’s senior vice president and chief financial officer, said the company’s cash runway, as previously announced in its Form 10-Q, extends through the second quarter of 2027.

Lo said Vaxart continues to pursue non-dilutive funding opportunities, including through entities such as BARDA, the Gates Foundation and other government sources. He noted that the Gates Foundation previously funded Vaxart’s lactating mother study and said the company remains in dialogue with the foundation.

Management also addressed Vaxart’s licensing agreement with Altesa Biosciences for Vapendavir. Lo said Vaxart is eligible to receive up to $130 million in total payments if Altesa is successful, including tiered royalties ranging from low single digits to low double digits based on global net product sales. He directed investors to the company’s Form 10-K for additional details.

In response to concerns about the company’s share price, Lo said management and the board share investors’ disappointment. Watson added that the board is focused on creating value for all shareholders, including Vaxart’s large retail investor base.

Lo also said Vaxart remains in contact with the Dynavax/Sanofi team and that they are aware of the company’s COVID-19, norovirus and flu programs.

About Vaxart (OTCMKTS:VXRT) Vaxart, Inc is a clinical-stage biotechnology company pioneering the development of oral recombinant vaccines administered in tablet form. Leveraging a proprietary, room-temperature-stable platform, the company aims to simplify vaccine delivery while eliciting both systemic and mucosal immune responses. Its technology is based on the replication-defective adenovirus vector system, which encodes target antigens designed to protect against a range of infectious diseases without the need for injections or cold-chain logistics.

The company’s pipeline includes multiple vaccine candidates in various stages of development.

, /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced plans to launch Sorghum basis futures. Trading is expected to start on August 24, 2026, pending regulatory review.

Sorghum is a versatile commodity uniquely positioned to meet global demand from the domestic feed industry, the international export market and, more recently, biofuels.

The new basis contract reflects the price difference between sorghum and corn, two types of grain used in animal feed as well as ethanol feedstock. Sorghum's premium over corn usually signals international demand driving values higher. A deep discount compels domestic buyers to shift feed rations toward cheaper sorghum.

"While sorghum prices tend to track corn closely over extended macroeconomic cycles, geopolitical events and regional supply shifts can disrupt that relationship," said John Ricci, Managing Director and Global Head of Agricultural Products, CME Group. "In recent years, the sorghum-to-corn cash spread has experienced considerable volatility, swinging from sharp premiums to steep discounts. The Sorghum futures contract will provide market participants a precise instrument to hedge that basis risk."

The contracts will be physically delivered, with grain being loaded out by truck or rail from a network of elevators in Kansas, the nation's largest sorghum-producing state, by using the established Kansas City Hard Red Winter Wheat delivery network.

CME Group achieved record quarterly volume of 2.1 million contracts for Agricultural products in Q2 2026. Corn futures and options reached record open interest of 4.1 million contracts in Q2 2026, with the second highest quarterly volumes on record at 695,000 contracts traded.

The new Sorghum basis futures contracts will be listed and subject to the rules of CBOT. For more information on these products, please visit  https://www.cmegroup.com/markets/agriculture/grains/sorghum. 

As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products and metals.  The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform.  In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing. 

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc.  CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc.  NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc.  COMEX is a trademark of Commodity Exchange, Inc. BrokerTec is a trademark of BrokerTec Americas LLC and EBS is a trademark of EBS Group LTD. The S&P 500 Index is a product of S&P Dow Jones Indices LLC ("S&P DJI"). "S&P®", "S&P 500®", "SPY®", "SPX®", US 500 and The 500 are trademarks of Standard & Poor's Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners. 

CME-G

SOURCE CME Group

CHICAGO--(BUSINESS WIRE)--Motorola Solutions (NYSE: MSI) today announced that its APX NEXT XN P25 smart radio and XVN500 remote speaker microphone (RSM) are the first in the industry to achieve the National Fire Protection Association's (NFPA) 1930 certification. This latest set of standards supersedes the NFPA 1802 certification, representing the highest level of ruggedization with new software safety protocols for flexible volume control, clearer diagnostics and automatic audio battery alerts.

DENVER--(BUSINESS WIRE)--Royal Gold Provides Preliminary Financial Information and Details for the Release of Financial Results for the Second Quarter 2026.

MCLEAN, Va.--(BUSINESS WIRE)--Capital One Financial Corporation (NYSE: COF) today announced net income for the second quarter of 2026 of $3.0 billion, or $4.73 per diluted common share, compared with net income of $2.2 billion, or $3.34 per diluted common share in the first quarter of 2026, and with net loss of $4.3 billion, or $(8.58) per diluted common share in the second quarter of 2025. Adjusted net income(1) for the second quarter of 2026 was $5.81 per diluted common share. "Our results in.

SEATTLE--(BUSINESS WIRE)--Expedia® today released its 2026 Island Hot List, revealing the Next Wave of island destinations gaining global momentum with searches for islands rising an average of 55% year-over-year,1 alongside social media mentions up 20%.2 Based on Expedia's search data, the Island Hot List highlights 10 fast-rising islands offering travelers an alternative to traditional hotspots, combining natural beauty, cultural depth, and sometimes better value. Expedia's 2026 Island Hot Li.

AppLovin (APP +1.01%) has been one of the biggest winners on the stock market since 2022 as the company has gone from a mobile-game maker to an adtech powerhouse after leveraging the ad tools it built inside its games.

Its ad business has been so successful that it sold off its mobile games business last year and is now a pure-play adtech company. However, the AI boom has brought a mixed bag for the company, and it's been pressured by the broader worries about disruption in the software sector. AI is a key component of Axon, its AI-powered advertising engine, but investors also seem to believe its competitive advantage is more vulnerable as AI tools become more widely embraced.

As a result, the stock slipped 24% through the first half of the year, according to data from S&P Global Market Intelligence. As you can see from the chart below, the stock pulled back in the first two months of the year, and then mostly traded sideways.

APP data by YCharts

What's happening with AppLovin A number of factors weighed on the stock to start the year. It faced a short-seller attack from CapitalWatch, which alleged that the company was avoiding typical anti-money-laundering controls and being financially unscrupulous in other ways. The company pushed back on the claims, calling them "false, misleading, and nonsensical." It's also faced similar short reports in the past, though none of the allegations have stuck.

Additionally, mobile game-related stocks initially fell after Google announced Project Genie, a new platform for AI game creation, which potentially threatens the app-based game ecosystem, which includes AppLovin, as much of its business comes from ads that run on mobile games.

AppLovin then plunged in February after it reported fourth-quarter earnings, even though it beat estimates. Revenue jumped 66% to $1.66 billion, and earnings per share nearly doubled to $3.24.

Nonetheless, the results were not enough to push the stock higher, especially due to signs that Meta Platforms was planning on competing for untracked ad traffic on Apple's iOS that it had historically ignored.

AppLovin redeemed itself in the first-quarter report in May as the stock moved up 6% after another round of strong results and rapid growth.

Image source: Getty Images.

What's next for AppLovin Despite fears about disruption from AI, Meta, or other weaknesses, AppLovin has continued to deliver impressive results. It generates blockbuster profit margins, a sign of competitive advantage, and it has begun repurchasing stock, showing management confidence in future growth.

If AppLovin maintains its current momentum, the stock will eventually bounce back.

New Y-style MC4 test leads enable safer operating voltage measurements on live PV systems without opening energized enclosures July 21, 2026 03:00 ET  | Source: Fluke Corporation

Eindhoven, Netherlands, July 21, 2026 (GLOBE NEWSWIRE) -- The new Fluke TLPV2 Solar Test Lead Set from Fluke Corporation gives solar technicians a safer way to measure operating voltage on energized photovoltaic (PV) systems without opening electrical enclosures or working around exposed live connections. Designed to enable touch-safe voltage measurements directly from PV module connections, the TLPV2 helps technicians capture critical performance data while systems remain operational.

As solar installations continue to grow in size and complexity, safely troubleshooting energized systems has become more critical than ever. Featuring a unique Y-style design with official Stäubli MC4 connectors that install directly in-line with PV modules, the Fluke TLPV2 Solar Test Lead Set transforms how technicians test live solar systems. It enables touch-safe operating voltage measurements and faster diagnostics while systems remain energized, all without opening live electrical enclosures or increasing exposure to electrical hazards.

“As solar systems become more complex, the tools technicians rely on must evolve to make safety non-negotiable,” said Will White, Senior Solar Product Manager at Fluke. “The TLPV2 represents a new approach to PV troubleshooting, one that delivers the visibility technicians need while reducing exposure to energized equipment. We’re helping customers solve problems faster while raising the standard for safety across the solar industry.”

The Fluke TLPV2 delivers several key benefits for solar installation, maintenance and troubleshooting professionals:

Improved technician safety by enabling operating voltage measurements without opening energized combiner boxes or inverters.Touch-safe testing with official Stäubli MC4 connectors and fully shrouded banana plug connections.CAT III 1500 V / CAT IV 1000 V safety ratings for use in demanding solar environments.Real-time operating voltage measurements that help technicians diagnose performance issues while systems are actively generating power.Compatibility with Fluke solar measurement tools, including the Fluke 393 FC Solar Clamp Meter, 283 FC/PV multimeter, and other meters accepting 4 mm shrouded banana plugs.Durable gold-plated contacts designed for long service life and reliable performance in the field.Included PV unlocking tool for safe disconnection of MC4 connectors during maintenance activities. The TLPV2 Solar Test Lead Set is ideal for PV system commissioning, inverter verification, troubleshooting, maintenance inspections, energy audits and system performance evaluations where operating voltage measurements are required.

For more information about the Fluke TLPV2 Solar Test Lead Set, please visit TLPV2 Solar Clamp Test Lead Set..

About Fluke 
Founded in 1948, Fluke Corporation is the world leader in compact, professional electronic test tools and software for measuring and condition monitoring. Fluke customers are technicians, engineers, electricians, maintenance managers, and metrologists who install, troubleshoot, and maintain industrial, electrical, and electronic equipment and calibration processes.  

###

FLUKE is a registered trademark of Fluke Corporation. For more information, visit the Fluke website. 

What is the Fluke TLPV2?
The Fluke TLPV2 Solar Test Lead Set is a Y-style MC4 test lead solution that enables solar technicians to safely measure operating voltage on energized PV systems without opening electrical enclosures. It helps simplify troubleshooting by providing real-time system measurements while keeping technicians away from live electrical components.

What are the safety-critical features of the TLPV2?
The TLPV2 enables touch-safe operating voltage measurements outside energized electrical enclosures and is rated CAT III 1500 V / CAT IV 1000 V for demanding solar environments. Its Stäubli MC4 connectors and fully shrouded banana plugs help provide secure, reliable connections during testing.

What are the major features of the TLPV2?
Key features include a Y-style in-line design for PV modules, official Stäubli MC4 connectors, compatibility with Fluke solar test tools, durable gold-plated contacts, and a design optimized for solar installation, maintenance, and troubleshooting applications.

New Fluke TLPV2 Solar Test Lead Set Eliminates Risky Live-Box Voltage Measurements New Fluke TLPV2 Solar Test Lead Set Eliminates Risky Live-Box Voltage Measurements

New Fluke TLPV2 Solar Test Lead Set Eliminates Risky Live-Box Voltage Measurements New Y-style MC4 test leads enable safer operating voltage measurements on live PV systems New Fluke TLPV2 Solar Test Lead Set Eliminates Risky Live-Box Voltage Measurements New Y-style MC4 test leads enable safer operating voltage measurements on live PV systems

Contact Data Olivia Kline Fluke Corporation [email protected]

ARLINGTON, Va.--(BUSINESS WIRE)--Homes.com, a leading online residential marketplace and part of CoStar Group (NASDAQ: CSGP), published the most expensive publicly marketed home sales across major U.S. metropolitan areas for the month of June. The full analysis is available here. The list highlights the top closed sales in leading markets nationwide based on publicly marketed transactions recorded in multiple listing service (MLS) data. June's highest-priced publicly marketed home sale occurred.

SAN FRANCISCO--(BUSINESS WIRE)--Samsara Inc. (“Samsara”) (NYSE: IOT), the pioneer of the Connected Operations® Platform, today introduced a new brand identity, the company's first major visual update since its founding. Built alongside customers and grounded in the world in which they operate, the new brand reflects a decade of work to bring AI-driven products to the physical world. Over the past decade, Samsara has evolved from a telematics solution into the AI orchestration layer for industri.

LOS ANGELES, July 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AeroVironment, Inc. (“AeroVironment” or “the Company”) (NASDAQ: AVAV) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between June 25, 2025 and March 10, 2026, inclusive (the “Class Period”), are encouraged to contact the firm before July 27, 2026.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. AeroVironment downplayed the threat of competition related to its work with the U.S. Space Force's Satellite Communication Augmentation Resource ("SCAR") program. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about AeroVironment, investors suffered damages.

Join the case to recover your losses

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

SOURCE:

 The Schall Law Firm

HILLSBORO, Ore.--(BUSINESS WIRE)---- $LSCC #CNSA20--Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that its Lattice MachXO5™-NX TDQ FPGA family was named a Gold winner in the “First-to-Market Innovation” category of the 2026 Globee® Awards for Technology. Lattice MachXO5-NX TDQ is the industry's first secure control FPGA family with full CNSA 2.0-compliant post-quantum cryptography, purpose-built to address both the encryption key establishment and digital signature requ.

LAS VEGAS--(BUSINESS WIRE)--Caesars Palace, one of the most iconic resorts on the Las Vegas Strip, is celebrating its 60th anniversary with limited-time culinary and cocktail experiences inspired by the flavors, traditions and timeless elegance of its opening era.*For high-res 60th anniversary food and beverage images, click here (credit: Caesars Entertainment)**For Caesars Palace historical images, click here (credit: LVCVA Archive)*Since opening in 1966, Caesars Palace has set the standard for.

Redwire Corporation is rated Hold with a $9.00 price target, reflecting 4% downside amid significant execution risk. RDW's record $498M backlog, 1.92 book-to-bill, and 26.6% gross margin are offset by flat organic growth, persistent cash burn, and 20% share dilution. Q2 2026 earnings are pivotal; sustained >25% gross margin, >$110M revenue, improved cash flow, and limited dilution are required for a positive rating event.

New York, New York--(Newsfile Corp. - July 21, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Futu Holdings Limited (NASDAQ: FUTU) between May 24, 2023 and May 27, 2026, inclusive (the "Class Period"), of the important August 25, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Futu securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Futu class action, go to https://rosenlegal.com/cases/futu-holdings-limited/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 25, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (1) Futu was not in compliance with the requirements of the China Securities Regulatory Commission (the "CSRC"), including because Futu continued to conduct securities business, public fund sales business and futures business in mainland China without obtaining the requisite licenses or approval; (2) as a result, Futu was reasonably likely to face regulatory penalties, including the disgorgement of ill-gotten gains and other penalties; (3) as a result of the foregoing, Futu's financial results were overstated; and (4) as a result of the foregoing, defendants' positive statements about Futu's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Futu class action, go to https://rosenlegal.com/cases/futu-holdings-limited/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/305952

Source: The Rosen Law Firm PA

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Alors que Mistral renforce ses capacités de calcul en IA en Europe, les deux entreprises renforcent leur partenariat stratégique grâce à l'engagement de Microsoft à exploiter une partie de ces capacités, ce qui permettra d'intégrer les modèles de pointe et performants de Mistral à la plateforme d'IA de Microsoft et d'offrir aux clients des options de déploiement flexibles, du cloud aux environnements complètement hors ligne 

Développer la capacité de calcul IA en Europe : Microsoft et Mistral annoncent un nouvel accord pour le développement d'infrastructures d'intelligence artificielle en Europe. Microsoft utilisera l'infrastructure GPU élargie de Mistral, basée en Europe, afin d'accroître sa capacité de développement en matière d'IA et de soutenir la fourniture de ses services cloud et d'IA. Cet engagement de plusieurs milliards de dollars de la part de Microsoft constitue un moyen important pour les clients de Microsoft de bénéficier des innovations scientifiques et informatiques de Mistral. Intégration des modèles Mistral dans les produits d'entreprise Microsoft : Mistral Medium 3.5 et OCR 4 sont désormais disponibles dans Microsoft Foundry et Mistral Medium 3.5 est désormais intégré à Microsoft Copilot Studio. Les clients de Microsoft dans le monde entier peuvent ainsi bénéficier des avantages des modèles de pointe, performants et multilingues de Mistral et les développeurs ont la possibilité de créer, de personnaliser et d'exploiter des applications d'IA. Offrir aux entreprises un meilleur contrôle sur l'IA à grande échelle : Azure permet aux entreprises de déployer des modèles Mistral dans des environnements cloud, connectés au cloud ou complètement hors réseau, tout en conservant le contrôle sur les données, les opérations et la continuité d'activité. , /PRNewswire/ -- Microsoft Corp. (Nasdaq : MSFT) et Mistral ont annoncé mardi un élargissement significatif de leur partenariat stratégique afin d'aider les entreprises et les secteurs réglementés à adopter les technologies d'IA d'avant-garde en leur offrant davantage de choix, de contrôle et de cohérence opérationnelle. Les deux entreprises intègrent les modèles innovants et performants de Mistral à la plateforme Microsoft, notamment Microsoft Foundry, Copilot Studio et Azure, afin de permettre aux clients de développer et d'exploiter l'IA dans un large éventail d'environnements d'exploitation, allant des déploiements à l'échelle du cloud aux opérations gérées par le client et complètement hors ligne.

Partout en Europe et sur d'autres marchés réglementés, les entreprises veulent accéder aux technologies d'IA d'avant-garde tout en conservant le contrôle de leurs données, de leurs opérations et de leurs charges de travail critiques. Ce partenariat élargit l'approche de cloud souverain de Microsoft en associant les modèles d'avant-garde de Mistral à la sécurité, à la conformité et à la plateforme cloud-to-edge de Microsoft, offrant ainsi aux clients davantage de choix quant à la manière et au lieu de déploiement de l'IA.

« L'Europe devrait pouvoir accéder aux technologies d'IA les plus performantes au monde sans pour autant compromettre le contrôle qu'elle exerce sur ses données, ses activités ou son avenir numérique », a déclaré Brad Smith, vice-président et président de Microsoft. « En intégrant les modèles européens de pointe de Mistral à notre portefeuille de solutions de cloud souverain et en les rendant disponibles dans des environnements de cloud public, connectés au cloud et totalement hors ligne, nous respectons les engagements numériques européens que nous avons pris et offrons à nos clients une base fiable pour l'IA, qu'ils peuvent exploiter au gré de leurs propres conditions. »

« Notre mission a toujours été de mettre l'IA d'avant-garde à la portée de toutes les organisations, tout en leur permettant de garder le contrôle de leur technologie », a déclaré Arthur Mensch, cofondateur et directeur général de Mistral. « Grâce à notre partenariat avec Microsoft, nos modèles sont mis à la disposition des entreprises et des institutions publiques à l'échelle mondiale, par l'intermédiaire d'une plateforme reconnue pour sa capacité à traiter des charges de travail les plus exigeantes et les plus réglementées et disponible partout où nos clients exercent leurs activités. »

L'avenir de l'IA en Europe : augmentation de la capacité des GPU

Ce partenariat est basé sur un nouvel accord de plusieurs milliards de dollars visant à développer les infrastructures d'intelligence artificielle en Europe. Mistral renforce sa capacité de calcul GPU en s'appuyant sur des milliers de GPU NVIDIA Vera Rubin de dernière génération afin d'accroître la disponibilité du calcul IA pour ses clients et de proposer une plateforme partagée pour l'entraînement, l'inférence et le déploiement à grande échelle.

Cet accord renforce l'infrastructure européenne en matière d'IA tout en aidant Microsoft à répondre à la demande croissante de services cloud et d'IA. Conformément à l'approche flexible de Microsoft en matière d'infrastructure mondiale, qui associe ses propres centres de données, des installations louées et des partenariats stratégiques avec des fournisseurs tiers, cette initiative renforce la présence de Microsoft en Europe et soutient les Engagements numériques européens annoncés en 2025.

« L'IA agentique suscite une demande sans précédent pour des infrastructures d'IA hautes performances et économes en énergie », a déclaré Ian Buck, vice-président chargé de l'informatique hyperscale et haute performance chez NVIDIA. « En déployant à grande échelle les systèmes NVIDIA Vera Rubin, Mistral et Microsoft offriront à leurs clients l'infrastructure informatique dont ils ont besoin pour développer et exploiter la prochaine génération d'IA en Europe et au-delà. »

L'IA d'avant-garde, prête pour les entreprises : modèles Mistral dans Microsoft Foundry et Copilot Studio

Au niveau de la plateforme, les derniers modèles de Mistral, Medium 3.5 et OCR 4, sont désormais disponibles dans Microsoft Foundry, permettant ainsi aux développeurs d'accéder à des modèles d'avant-garde au sein d'un environnement cohérent pour créer, personnaliser et déployer des applications IA. Mistral Medium 3.5 intègre un modèle à poids ouvert dans un environnement Azure géré, permettant ainsi aux développeurs et aux entreprises de créer, personnaliser et déployer des applications d'IA tout en bénéficiant d'un contrôle total, d'options de déploiement souveraines et d'une évolutivité prévisible et rentable. OCR 4 prend en charge les pipelines de traitement de documents structurés et les workflows basés sur des agents ; ces deux modèles peuvent être appliqués à des applications basées sur des agents, à l'automatisation et à des solutions spécifiques à un domaine, à l'aide des outils et des workflows déjà en place sur la plateforme Foundry.

Au niveau de la couche applicative, les entreprises ont intégré le modèle Medium 3.5 de Mistral à Copilot Studio, alliant ainsi la flexibilité du modèle à une gouvernance de niveau entreprise. Cela permet aux équipes de choisir le modèle le mieux adapté à un scénario donné, tout en conservant le contrôle sur la manière dont les données sont traitées et sur le lieu du traitement.

Une expérience de déploiement unique, quel que soit l'environnement : Microsoft Foundry et Foundry Local

Les entreprises peuvent développer des applications IA en utilisant les mêmes modèles, outils, API et flux de travail sur Microsoft Foundry et Foundry Local. Les équipes disposent ainsi d'une méthode cohérente pour développer, personnaliser et exploiter des applications IA, quel que soit l'environnement dans lequel ces applications seront finalement exécutées.

Microsoft Foundry fournit une plateforme de développement permettant de découvrir, de créer et de déployer des modèles et des agents dans le cloud. Foundry Local étend cette expérience de développement et d'exécution à Azure Local, permettant ainsi aux entreprises de rapprocher l'IA de leurs données, de leurs utilisateurs et de leurs environnements opérationnels. Ensemble, ces éléments limitent la nécessité de repenser les applications pour chaque scénario de déploiement, tout en offrant aux clients davantage de flexibilité pour répondre aux exigences en matière de souveraineté, de latence et de résilience.

Un déploiement flexible grâce à un modèle opérationnel commun : Azure et Azure Local

Les organisations ont de plus en plus besoin de différents niveaux de contrôle opérationnel en fonction de la sensibilité de la charge de travail, des obligations réglementaires et des exigences liées à leur mission. Azure et Azure Local offrent une plateforme commune prenant en charge les déploiements d'IA dans un large éventail d'environnements d'exploitation :

Le cloud : déploiements hébergés sur Azure pour bénéficier d'une évolutivité à l'échelle du cloud, d'une grande agilité et d'un accès aux dernières innovations de la plateforme. Connecté au cloud : des environnements Azure Local gérés par le client qui restent connectés aux services et aux opérations Azure lorsque cela est nécessaire. Complètement déconnecté : déploiements Azure Local pouvant fonctionner indépendamment de toute connexion externe, destinés aux environnements hautement sensibles, soumis à des contraintes ou critiques. Quel que soit le modèle d'exploitation choisi, les clients peuvent utiliser les modèles Mistral en bénéficiant d'une plateforme et d'une approche opérationnelle cohérentes. Cela permet aux organisations soumises à une réglementation d'éviter une architecture d'IA fragmentée, tout en garantissant le niveau de contrôle, de résilience et de connectivité requis par leurs charges de travail. 

Pour les secteurs réglementés où l'autonomie stratégique est indispensable, cela présente des avantages concrets. Ces clients peuvent utiliser l'IA dans des processus critiques tout en adaptant les données, les opérations et les contrôles d'accès à leurs besoins spécifiques. Les opérateurs d'infrastructures critiques peuvent maintenir des capacités d'IA là où la résilience et la continuité de service sont essentielles. Les entreprises du secteur manufacturier et industriel peuvent analyser localement les données relatives à la production, la qualité et les opérations, là où la latence, la protection de la propriété intellectuelle, les contrôles à l'exportation, la cybersécurité et la résilience de la chaîne d'approvisionnement peuvent influencer les exigences de déploiement. Les établissements de santé peuvent mettre en place des processus de travail basés sur l'IA, dans lesquels la protection de la vie privée, la localisation des données, la continuité des soins et le traitement des données conformément à la réglementation constituent des exigences fondamentales.

Bénéfices pour nos clients

Dans le cadre de ce renforcement de leur collaboration, les deux entreprises vont utiliser un plan de commercialisation commun et exploiter ensemble des opportunités auprès des grandes entreprises, tant en Europe qu'à l'échelle mondiale. Mistral et Microsoft étendent également leur partenariat afin d'accélérer l'adoption par les clients, notamment en finançant des démonstrations de faisabilité (PoC), en offrant des crédits Azure et en organisant des ateliers destinés à stimuler l'innovation en matière d'IA avec leurs clients.

Les entreprises des secteurs des services financiers, de l'industrie manufacturière, de la santé et d'autres secteurs réglementés exploitent l'IA dans des environnements dans lesquels le contrôle et la résilience sont indispensables. Grâce à ce partenariat, ils peuvent développer des applications d'IA dans Microsoft Foundry et les exécuter sur Azure ou sur Azure Local, en utilisant les modèles Mistral dans des environnements de fonctionnement dans le cloud, connectés au cloud ou complètement hors ligne.

Microsoft et Mistral vont continuer de travailler pour leurs clients tout en innovant dans les domaines des modèles, de l'expérience de développement, de la plateforme de développement et de l'infrastructure européenne d'IA qui rendent cela possible.

Informations supplémentaires

Pour en savoir plus, veuillez cliquer sur le lien suivant : www.mistral.ai Découvrez Microsoft Sovereign Cloud : https://www.microsoft.com/en-us/sovereignty En savoir plus sur Azure Local : https://azure.microsoft.com/en-us/products/local En savoir plus sur Microsoft Foundry : https://azure.microsoft.com/en-us/products/ai-foundry En savoir plus sur Microsoft Copilot Studio : https://www.microsoft.com/en-us/microsoft-365-copilot/microsoft-copilot-studio À propos de Mistral

Mistral est un pionnier de l'IA générative qui fournit au monde les outils nécessaires pour construire et tirer profit de la technologie la plus transformatrice de notre époque. L'entreprise démocratise l'IA grâce à des modèles, des produits et des solutions open source hautement performants, optimisés et à la pointe de la technologie, ainsi qu'à une infrastructure de bout en bout avec Mistral Compute. Basée en France et indépendante, Mistral prône une approche décentralisée et transparente de la technologie, et bénéficie d'une forte présence internationale aux États-Unis, au Royaume-Uni et à Singapour. Pour en savoir plus, veuillez consulter www.mistral.ai

À propos de Microsoft

Microsoft (Nasdaq « MSFT » @microsoft) crée des plateformes et des outils activés par l'IA pour offrir des solutions innovantes répondant aux besoins en constante évolution de nos clients. L'entreprise technologique s'est engagée à rendre l'IA largement disponible et à le faire de manière responsable, avec pour mission de permettre à chaque personne et à chaque organisation de la planète d'accomplir davantage.

Nike is tightening online sales in China as it tries to restore pricing power and reverse a deepening decline in its third-largest market.

From January 2027, most of Nike’s 16 major Chinese retail partners will stop selling its products online and focus on physical stores.

Those partners operate thousands of Nike outlets, but the company is not cutting off thousands of separate distributors.

Digital sales will instead move through Nike-branded storefronts on Tmall, JD.com and Douyin, alongside its website and app.

The strategy could reduce discounting and improve control over customer data and presentation.

Greater China sales fell 17% on a constant-currency basis in the latest quarter, underscoring that tighter distribution must be matched by stronger product demand to revive the business.

Nike stock NYSE:NKE closed 1.2% lower at $42.96 on Tuesday, reflecting continued investor caution over the pace of its turnaround.

Nike believes its Chinese digital marketplace has become fragmented, with products sold by multiple retailers at different prices.

“Our marketplace has become so fragmented and cluttered,” Greater China chief Cathy Sparks told Reuters.

She said consumers wanted an experience that was premium and trustworthy.

By concentrating e-commerce through official storefronts, Nike can coordinate launches, reduce competition between sellers and encourage full-price purchases.

Retail partners will continue operating physical stores, so the overhaul is not a complete retreat from wholesale.

The disruption for partners could be considerable, as Topsports, which generates 22% of its revenue from online Nike sales, warned of a significant short-term impact.

Shares in Topsports and fellow distributor Pou Sheng fell sharply after the plan was confirmed.

For Nike, the trade-off is to sacrifice some reach for tighter control over pricing and inventory.

Nike is taking the risk because its China recovery continues to disappoint. The latest 17% sales decline worsened from a 10% fall in the previous quarter, while Anta and Li Ning gained share.

On and Hoka have also captured demand in performance running and faster-growing categories.

Excessive discounting is only part of the problem. Chinese shoppers have more credible choices, while rivals have often moved faster on local preferences and performance products.

Nike has appointed a vice-president of local product creation in Greater China, signalling that management recognises the need for market-specific products.

“The Nike turnaround is progressing slowly,” Telsey Advisory Group analyst Cristina Fernandez told Reuters.

She said weakness in sportswear and international markets was unlikely to reverse meaningfully before fiscal 2028.

Jefferies analysts similarly said sportswear and Jordan streetwear remained an overhang, although Nike’s core business was stabilising.

Wistron Corporation shares jumped 9.7% on Wednesday after the Taiwan-based technology service provider announced the opening of its first U.S. facility to build AI servers for Nvidia.

Its D1 AI smart facility, a $700 million, 324,000-square-foot site in Fort Worth, Texas, currently produces Nvidia's GB300 Grace Blackwell Ultra Superchip, an advanced AI processing platform. It will later expand to produce Nvidia's Vera Rubin Superchip, which is critical to powering the next generation of AI computing. 

"In the next couple of years, this location will be one of the most important, as we build AI infrastructure here in the United States," Wistron Chairman Simon Lin said in the press release.

The new footprint highlights a broader trend of Taiwanese tech giants expanding their footprint in the U.S., following TSMC's announcement last week that it is doubling down on its investment in Arizona. 

Wistron's new facility will ramp up production of Nvidia AI servers, expanding domestic capacity to assemble and test the systems, which integrate into Nvidia's DSX infrastructure to deploy energy-efficient AI factories at scale.

Wistron said it is creating a new model for AI infrastructure production built on digital manufacturing, energy optimization and local operations. 

"Demand for AI factories—the engine of this next industrial revolution—is incredible, and they must be produced everywhere," Jensen Huang, chief executive officer of Nvidia, said.

Wistron said the Fort Worth plant will serve as the core engine of its U.S. manufacturing operations, adding that the investment reflects the next phase of AI infrastructure development.

Nvidia's partner manufacturing facilities span 43 U.S. states, with partners including Wistron, TSMC and Foxconn, contributing an estimated $485 billion to the U.S. GDP in 2026.

TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (“Mitsubishi Electric”) and Sony Semiconductor Solutions Corporation (“Sony”) have entered into a definitive agreement on a strategic partnership aimed at accelerating the automation and advancement of manufacturing equipment and manual operations in the manufacturing industry. Under the partnership, the two companies will establish a newly formed joint venture (“JV”), Advanced Vision Solutions Co., Ltd., which is scheduled to begin operat.

[url="]The Schall Law Firm[/url], a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pentair plc

Cena za ochranu proti defaultu dluhu velkých technologických firem rychle roste. Pětileté CDS spready, které určují cenu pojištění proti nesplácení dluhu, se v případě hyperscalerů vyšplhaly na 75 bazických bodů, což je nejvyšší úroveň za posledních sedm let.

Významný podíl na růstu ceny zajištění má zejména Oracle. Pětiletý CDS spread firmy překonal hranici 200 bazických bodů a dostal se nad dosavadní vrchol z konce roku 2008. Výrazně vyšší cenu za zajištění dluhu Oraclu požadovali investoři také v období kolem roku 2022.

— The Kobeissi Letter (@KobeissiLetter) July 16, 2026 Samotný růst CDS spreadů přitom neznamená blížící se katastrofu. Naznačuje spíše vyšší opatrnost investorů a zaceňování případného negativního scénáře. Vyšší poptávka po zajištění dluhu následně automaticky žene jeho cenu vzhůru.

Svůj podíl na růstu ceny zajištění má pravděpodobně i čínská firma Kimi AI a její open-source model K3, který v posledních testech porazil americkou konkurenci včetně OpenAI a Anthropicu. Mezi investory se tak znovu rozšířily obavy ohledně toho, zda jsou obří investice do rozvoje umělé inteligence opodstatněné, nebo zda jde o závod v utrácení bez jednoznačného vítěze.

Oracle patří mezi firmy s nejagresivnější investiční strategií a ve značné míře sází na OpenAI a plnění nasmlouvaných kontraktů. Rostoucí nejistota ohledně návratnosti investic se proto rychle promítla do dluhopisů společnosti, které oslabovaly napříč celou výnosovou křivkou.

Oracle jako největší emitent dluhu v koši firem zahrnutých do indexu US High Grade Corporate Bond Ex-Financials podle některých analytiků slouží jako barometr nervozity na trhu dluhopisů spojených s AI. Analytička Morgan Stanley Lindsay Tyler upozorňuje, že investoři by nyní měli bedlivě sledovat kreditní ratingy jednotlivých firem.

V případě Oraclu například agentura S&P snížila rating na BBB-, tedy pouze jeden stupeň nad spekulativním pásmem. Moody's aktuálně drží hodnocení Baa2. Pro srovnání, Alphabet má na stupnici Moody's rating Aa2, Amazon A1, Nvidia Aa1 a SpaceX Baa1.

Z pohledu investora může být zajímavý také ukazatel GSUCHS30 spravovaný investiční bankou Goldman Sachs, který sleduje g-spread (rozdíl mezi výnosy státních a daných korporátních dluhopisů) dluhu technologických firem ze skupiny „ultra-large-cap“, nesoucích většinu nákladů spojených s rozvojem AI infrastruktury. Historie indexu je poměrně krátká, přesto vykazuje rozšíření spreadu, což naznačuje vyšší požadovanou kompenzaci ze strany věřitelů.

Hnacím motorem nervozity je růst zadlužení hyperscalerů. Vysoké investice do AI infrastruktury již firmy nedokážou plně financovat z provozního cash flow, a musí tak emitovat nový dluh nebo vydávat další akcie.

Amazon, Alphabet, Nvidia, Meta, Oracle a SpaceX během letoška vydaly dluhopisy již za 182 miliard dolarů, což představuje meziroční nárůst o 1300 %. Celkově emise hyperscalerů letos tvoří přibližně 15 % objemu všech korporátních dluhopisů.

Klíčovou otázkou tak zůstává, jak dlouho bude současný trend pokračovat. S dalšími emisemi bude růst citlivost dluhopisového i akciového trhu na negativní zprávy týkající se návratnosti investic. Zatím však platí, že poptávka po expozici na AI zůstává vysoká a firmy nemají problémy upisovat nový dluh ani emitovat další akcie.